NASDAQ: SPROSpero Therapeutics Inc Stock Ownership - Who owns Spero Therapeutics?
Insider buying vs selling
Have Spero Therapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Esther Rajavelu | Chief Executive Officer Chief Financial Officer and Chief Business Officer | 2026-05-04 | 25,240 | $2.51 | $63.35kSell |
| Esther Rajavelu | Chief Executive Officer Chief Financial Officer and Chief Business Officer | 2026-02-06 | 37,101 | $2.36 | $87.56kSell |
| Esther Rajavelu | Chief Executive Officer Chief Financial Officer and Chief Business Officer | 2026-02-06 | 50,816 | $2.36 | $119.93kSell |
| Timothy Keutzer | Chief Operating Officer | 2026-02-06 | 18,652 | $2.36 | $44.02kSell |
| Timothy Keutzer | Chief Operating Officer | 2026-02-04 | 3,471 | $2.24 | $7.78kSell |
| Timothy Keutzer | Chief Operating Officer | 2026-02-03 | 24,224 | $2.14 | $51.84kSell |
| Timothy Keutzer | Chief Operating Officer | 2026-02-02 | 18,891 | $2.20 | $41.56kSell |
| Esther Rajavelu | Chief Executive Officer Chief Financial Officer and Chief Business Officer | 2026-02-02 | 18,442 | $2.20 | $40.57kSell |
| Esther Rajavelu | Chief Executive Officer Chief Financial Officer and Chief Business Officer | 2025-11-07 | 40,270 | $2.37 | $95.44kSell |
SPRO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when SPRO insiders and whales buy or sell their stock.
SPRO Shareholders
What type of owners hold Spero Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Aquilo Capital Management LLC | 19.93% | 11,606,674 | $13.81M | Insider |
| Gsk PLC | 15.78% | 9,190,606 | $10.94M | Insider |
| Glaxosmithkline PLC | 6.50% | 3,788,012 | $4.51M | Insider |
| Jean Francois Formela | 4.14% | 2,408,128 | $2.87M | Insider |
| Vikas Goyal | 3.18% | 1,854,006 | $2.21M | Insider |
| Sath Shukla | 2.98% | 1,736,883 | $2.07M | Insider |
| Casper Breum | 1.87% | 1,091,774 | $1.30M | Insider |
| Esther Rajavelu | 1.69% | 986,851 | $1.17M | Insider |
| Kamal Hamed | 1.35% | 788,117 | $937.86k | Insider |
| Timothy Keutzer | 1.28% | 742,506 | $883.58k | Insider |
SPRO vs Biotech Stocks
Spero Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.